[HTML][HTML] The role of the CXCL12/CXCR4/ACKR3 axis in autoimmune diseases

EM García-Cuesta, CA Santiago… - Frontiers in …, 2019 - frontiersin.org
Chemokine receptors are members of the G protein-coupled receptor superfamily. These
receptors are intimately involved in cell movement, and thus play a critical role in several …

CXCL12/CXCR4 signal transduction in diseases and its molecular approaches in targeted-therapy

A Mousavi - Immunology Letters, 2020 - Elsevier
Chemokines are small molecules called “chemotactic cytokines” and regulate many
processes like leukocyte trafficking, homing of immune cells, maturation, cytoskeletal …

Peripheral regulatory T lymphocytes recirculating to the thymus suppress the development of their precursors

N Thiault, J Darrigues, V Adoue, M Gros, B Binet… - Nature …, 2015 - nature.com
Most T lymphocytes, including regulatory T cells (Treg cells), differentiate in the thymus. The
age-dependent involution of this organ leads to decreasing production of T cells. Here we …

Polyfunctionality of the CXCR4/CXCL12 axis in health and disease: Implications for therapeutic interventions in cancer and immune‐mediated diseases

C Britton, MC Poznansky, P Reeves - The FASEB Journal, 2021 - Wiley Online Library
Historically the chemokine receptor CXCR4 and its canonical ligand CXCL12 are
associated with the bone marrow niche and hematopoiesis. However, CXCL12 exhibits …

Immunological applications of stem cells in type 1 diabetes

P Fiorina, J Voltarelli, N Zavazava - Endocrine reviews, 2011 - academic.oup.com
Current approaches aiming to cure type 1 diabetes (T1D) have made a negligible number of
patients insulin-independent. In this review, we revisit the role of stem cell (SC)-based …

CXCR4 antagonist AMD3100 redistributes leukocytes from primary immune organs to secondary immune organs, lung, and blood in mice

Q Liu, Z Li, JL Gao, W Wan, S Ganesan… - European journal of …, 2015 - Wiley Online Library
AMD3100 (plerixafor), is a specific CXCR4 antagonist approved by the FDA for mobilizing
hematopoietic stem cells from bone marrow to blood for transplantation in cancer. AMD3100 …

[HTML][HTML] Stem cell transplantation in the treatment of type 1 diabetes mellitus: from insulin replacement to beta-cell replacement

XX Wan, DY Zhang, MA Khan, SY Zheng… - Frontiers in …, 2022 - frontiersin.org
Type 1 diabetes mellitus (T1DM) is an autoimmune disease that attacks pancreatic β-cells,
leading to the destruction of insulitis-related islet β-cells. Islet β-cell transplantation has been …

CXCR4, but not CXCR3, drives CD8+ T‐cell entry into and migration through the murine bone marrow

M Goedhart, S Gessel, R van der Voort… - European journal of …, 2019 - Wiley Online Library
The BM serves as a blood‐forming organ, but also supports the maintenance and immune
surveillance function of many T cells. Yet, in contrast to other organs, little is known about the …

[HTML][HTML] Vascular dysfunction in diabetes: The endothelial progenitor cells as new therapeutic strategy

A Georgescu - World journal of diabetes, 2011 - ncbi.nlm.nih.gov
The vascular endothelium is a critical determinant of diabetes-associated vascular
complications, and improving endothelial function is an important target for therapy …

The CXCR4-CXCL12 pathway facilitates the progression of pancreatic cancer via induction of angiogenesis and lymphangiogenesis

K Cui, W Zhao, C Wang, A Wang, B Zhang… - Journal of Surgical …, 2011 - Elsevier
BACKGROUND: This study reports the influence of CXCL12 and its receptor CXCR4 on the
progression of pancreatic cancer and illuminates the correlation between the …